Tag: SABR
“Bureaucratic hurdles” and “gross inequality” must be addressed in delayed NHS...
First expected in late 2025, the UK National Health Service (NHS) 10-year cancer plan, setting out a comprehensive strategy for oncology funding and care...
Phase 2 trial demonstrates potential of medication-free treatment for metastatic kidney...
Building upon “pioneering work” at University of Texas Southwestern (UTSW) Medical Center (Dallas, USA), investigators recently reported the results of a clinical trial exploring the role of...
CROSSFIRE trial: IRE induces a more immune-permissive environment in pancreatic cancer...
Irreversible electroporation (IRE) significantly induces a window of reduced immune suppression two weeks post treatment, allowing the activation of effector T cells that seem...
